NGN Optiscan Fund I, L.P. is a private investment fund based in New York, New York. Its most recent Form D, filed Apr 17, 2018, reports no sales yet. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include NGN Capital LLC; NGN BioMed I GP, L.P.
- Total raised
- $0Cumulative sales reported on Form D
- Investors
- 0
- First sale
- —
- Minimum investment
- None set
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- NGN Capital LLC; NGN BioMed I GP, L.P
- Latest Form D
- Apr 17, 2018
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about NGN Optiscan Fund I, L.P.
What is the minimum investment for NGN Optiscan Fund I, L.P.?
NGN Optiscan Fund I, L.P.'s latest Form D, filed Apr 17, 2018, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in NGN Optiscan Fund I, L.P.?
NGN Optiscan Fund I, L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.
How much has NGN Optiscan Fund I, L.P. raised?
NGN Optiscan Fund I, L.P.'s latest Form D, filed Apr 17, 2018, reports no sales yet.
Where is NGN Optiscan Fund I, L.P. based?
NGN Optiscan Fund I, L.P. is based in New York, New York.
Size compared with every private investment fund
This fund hasn't reported any sales yet.